Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
D000818:Animals; D002320:Cardiovascular Physiological Phenomena; D011464:Epoprostenol / Q000378:metabolism*; D005227:Fatty Acids / Q000502:physiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006487:Hemostasis; D006801:Humans; D011453:Prostaglandins / Q000378:metabolism* / Q000502:physiology; D013927:Thrombosis / Q000503:physiopathology; D013928:Thromboxane A2 / Q000378:metabolism*; D013931:Thromboxanes / Q000378:metabolism*
D005227:Fatty Acids; D005343:Fibrinolytic Agents; D011453:Prostaglandins; D013931:Thromboxanes; D013928:Thromboxane A2; D011464:Epoprostenol